leucovorin calcium / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 424 Diseases   807 Trials   807 Trials   14372 News 


«12...213214215216217218219220221222223...235236»
  • ||||||||||  leucovorin calcium / Generic mfg.
    Enrollment change:  A Folinic Acid Intervention for Autism Spectrum Disorders (clinicaltrials.gov) -  Aug 29, 2014   
    P2,  N=192, Recruiting, 
    Trial primary completion date: Sep 2016 --> Mar 2017 N=144 --> 192
  • ||||||||||  TheraSphere (yttrium 90 microspheres) / Boston Scientific
    Enrollment closed, Trial primary completion date:  Phase II Trial Evaluating OS With Therasphere (clinicaltrials.gov) -  Aug 21, 2014   
    P2,  N=58, Active, not recruiting, 
    Active, not recruiting --> Recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2016 --> Mar 2015
  • ||||||||||  telisotuzumab (h224G11) / AbbVie
    Trial primary completion date, Metastases:  Study of ABT-700 in Subjects With Advanced Solid Tumors (clinicaltrials.gov) -  Aug 19, 2014   
    P1,  N=124, Recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2016 --> Mar 2015 Trial primary completion date: Dec 2014 --> Dec 2015
  • ||||||||||  Trial primary completion date, Metastases:  Molecularly Tailored Therapy for Pancreas Cancer (clinicaltrials.gov) -  Aug 15, 2014   
    P2,  N=20, Recruiting, 
    Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Dec 2014 --> Jun 2015
  • ||||||||||  5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg., irinotecan / Generic mfg.
    Trial primary completion date, Metastases:  Trial of FOLF(HA)Iri Versus FOLFIRI in mCRC (clinicaltrials.gov) -  Aug 15, 2014   
    P3,  N=390, Active, not recruiting, 
    Trial primary completion date: Dec 2014 --> Jun 2015 Trial primary completion date: Jan 2014 --> Sep 2014
  • ||||||||||  Avastin (bevacizumab) / Roche, GI-4000 / ImmunityBio
    Enrollment closed, Metastases:  A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRI (clinicaltrials.gov) -  Aug 15, 2014   
    P2,  N=52, Active, not recruiting, 
    Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
  • ||||||||||  Zaltrap (ziv-aflibercept IV) / Sanofi
    Trial initiation date, Metastases:  FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer (clinicaltrials.gov) -  Aug 11, 2014   
    P2,  N=64, Recruiting, 
    Recruiting --> Active, not recruiting | N=800 --> 564 Initiation date: Jan 2013 --> Sep 2013
  • ||||||||||  Rituxan (rituximab) / Roche
    Trial primary completion date, Combination therapy:  R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma (clinicaltrials.gov) -  Aug 8, 2014   
    P2,  N=22, Active, not recruiting, 
    Initiation date: Jan 2013 --> Sep 2013 Trial primary completion date: Apr 2014 --> Apr 2015
  • ||||||||||  Trial primary completion date:  A Study in Adults With Untreated Acute Lymphoblastic Leukemia (clinicaltrials.gov) -  Jul 30, 2014   
    P2,  N=100, Active, not recruiting, 
    Recruiting --> Active, not recruiting Trial primary completion date: Jun 2014 --> Dec 2014
  • ||||||||||  Erbitux (cetuximab) / Eli Lilly
    Enrollment open, Trial initiation date, Trial primary completion date, Surgery, Metastases:  ECKINOXE: Trial of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer (clinicaltrials.gov) -  Jul 30, 2014   
    P2,  N=186, Recruiting, 
    Trial primary completion date: Jun 2014 --> Dec 2014 Not yet recruiting --> Recruiting | Initiation date: Jan 2014 --> May 2012 | Trial primary completion date: Feb 2014 --> May 2012
  • ||||||||||  thioguanine / Generic mfg.
    Trial completion, Enrollment change:  Combination Chemotherapy in Treating Children With Lymphoma (clinicaltrials.gov) -  Jul 24, 2014   
    P2,  N=221, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | N=90 --> 221
  • ||||||||||  sapitinib (AZD8931) / AstraZeneca
    Enrollment open, Trial initiation date, Combination therapy:  PANTHER: Phase I/II Trial of Antagonism of HER in GI Cancer (clinicaltrials.gov) -  Jul 23, 2014   
    P1/2,  N=24, Recruiting, 
    Active, not recruiting --> Completed | N=90 --> 221 Not yet recruiting --> Recruiting | Initiation date: Aug 2013 --> May 2014